2022
DOI: 10.3310/ulti9178
|View full text |Cite
|
Sign up to set email alerts
|

End-of-life care for people with severe mental illness: the MENLOC evidence synthesis

Abstract: Background People with severe mental illness have significant comorbidities and a reduced life expectancy. This project answered the following question: what evidence is there relating to the organisation, provision and receipt of care for people with severe mental illness who have an additional diagnosis of advanced incurable cancer and/or end-stage lung, heart, renal or liver failure and who are likely to die within the next 12 months? Objec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 319 publications
(730 reference statements)
0
4
0
Order By: Relevance
“… 84 Recent reviews and synthesis of evidence describing clinical care in this field reveal similarly variable provision. 85–87 Research on EoL care for people with mental health problems is limited 35 and in the absence of high-quality intervention research, case studies provide an important source of knowledge. While there is much to learn from case studies, the reporting of clinical details is variable, thus limiting generalisation.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“… 84 Recent reviews and synthesis of evidence describing clinical care in this field reveal similarly variable provision. 85–87 Research on EoL care for people with mental health problems is limited 35 and in the absence of high-quality intervention research, case studies provide an important source of knowledge. While there is much to learn from case studies, the reporting of clinical details is variable, thus limiting generalisation.…”
Section: Discussionmentioning
confidence: 99%
“…The protocol is registered in PROSPERO (see online supplemental file 1 ) and followed the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 38 (see online supplemental file 2 ). The methods are reported in detail in the full project report 35 and summarised here.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations